Studies have shown that Tregs express a variety of chemokine receptors, such as CCR4, CCR5, CCR8 and CCR10, which can respond to a variety of chemokines released during tumor growth, and then participate in the migration of Tregs to tumor tissues [20–22]. The gene discussed is CCR5; the disease is neoplasm.